BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35596238)

  • 1. The polytomous discrimination index for prediction involving multistate processes under intermittent observation.
    Jiang S; Cook RJ
    Stat Med; 2022 Aug; 41(19):3661-3678. PubMed ID: 35596238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the discriminative ability of risk models for more than two outcome categories.
    Van Calster B; Vergouwe Y; Looman CW; Van Belle V; Timmerman D; Steyerberg EW
    Eur J Epidemiol; 2012 Oct; 27(10):761-70. PubMed ID: 23054032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polytomous diagnosis of ovarian tumors as benign, borderline, primary invasive or metastatic: development and validation of standard and kernel-based risk prediction models.
    Van Calster B; Valentin L; Van Holsbeke C; Testa AC; Bourne T; Van Huffel S; Timmerman D
    BMC Med Res Methodol; 2010 Oct; 10():96. PubMed ID: 20961457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computing the polytomous discrimination index.
    Dover DC; Islam S; Westerhout CM; Moore LE; Kaul P; Savu A
    Stat Med; 2021 Jul; 40(16):3667-3681. PubMed ID: 33866577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fitting multistate transition models with autoregressive logistic regression: supervised exercise in intermittent claudication.
    de Vries SO; Fidler V; Kuipers WD; Hunink MG
    Med Decis Making; 1998; 18(1):52-60. PubMed ID: 9456209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the polytomous logistic regression and joint cox proportional hazards models for evaluating multiple disease subtypes in prospective cohort studies.
    Xue X; Kim MY; Gaudet MM; Park Y; Heo M; Hollenbeck AR; Strickler HD; Gunter MJ
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):275-85. PubMed ID: 23292084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polytomous logistic regression analysis could be applied more often in diagnostic research.
    Biesheuvel CJ; Vergouwe Y; Steyerberg EW; Grobbee DE; Moons KG
    J Clin Epidemiol; 2008 Feb; 61(2):125-34. PubMed ID: 18177785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conditional Markov model for clustered progressive multistate processes under incomplete observation.
    Cook RJ; Yi GY; Lee KA; Gladman DD
    Biometrics; 2004 Jun; 60(2):436-43. PubMed ID: 15180669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonparametric estimation and inference for polytomous discrimination index.
    Li J; Feng Q; Fine JP; Pencina MJ; Van Calster B
    Stat Methods Med Res; 2018 Oct; 27(10):3092-3103. PubMed ID: 28178877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extending the c-statistic to nominal polytomous outcomes: the Polytomous Discrimination Index.
    Van Calster B; Van Belle V; Vergouwe Y; Timmerman D; Van Huffel S; Steyerberg EW
    Stat Med; 2012 Oct; 31(23):2610-26. PubMed ID: 22733650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Score tests based on a finite mixture model of Markov processes under intermittent observation.
    Jiang S; Cook RJ
    Stat Med; 2019 Jul; 38(16):3013-3025. PubMed ID: 30972787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling multiple correlated end-organ disease trajectories: A tutorial for multistate and joint models with applications in diabetes complications.
    Lovblom LE; Briollais L; Perkins BA; Tomlinson G
    Stat Med; 2024 Feb; 43(5):1048-1082. PubMed ID: 38118464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing calibration of multinomial risk prediction models.
    Van Hoorde K; Vergouwe Y; Timmerman D; Van Huffel S; Steyerberg EW; Van Calster B
    Stat Med; 2014 Jul; 33(15):2585-96. PubMed ID: 24549725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A joint modelling approach for multistate processes subject to resolution and under intermittent observations.
    Yiu S; Tom B
    Stat Med; 2017 Feb; 36(3):496-508. PubMed ID: 27753134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Framework for Modeling and Interpreting Patient Subgroups Applied to Hospital Readmission: Visual Analytical Approach.
    Bhavnani SK; Zhang W; Visweswaran S; Raji M; Kuo YF
    JMIR Med Inform; 2022 Dec; 10(12):e37239. PubMed ID: 35537203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Markov multistate analysis of the relationship between performance status and death among an ambulatory population of cancer patients.
    Sutradhar R; Barbera L
    Palliat Med; 2014 Feb; 28(2):184-90. PubMed ID: 23935016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of competing risks prediction models using polytomous discrimination index.
    Ding M; Ning J; Li R
    Can J Stat; 2021 Sep; 49(3):731-753. PubMed ID: 34707327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marker-dependent observation and carry-forward of internal covariates in Cox regression.
    Cook RJ; Lawless JF; Xie B
    Lifetime Data Anal; 2022 Oct; 28(4):560-584. PubMed ID: 35725841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multistate Models for Examining the Progression of Intermittently Measured Patient-Reported Symptoms Among Patients With Cancer: The Importance of Accounting for Interval Censoring.
    Sutradhar R; Barbera L
    J Pain Symptom Manage; 2021 Jan; 61(1):54-62. PubMed ID: 32688014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.